The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
 
Jose Manuel Ruiz Morales
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
J Connor Wells
No Relationships to Disclose
 
Frede Donskov
Honoraria - Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Georg A. Bjarnason
No Relationships to Disclose
 
Jae-Lyun Lee
Honoraria - Pfizer
Consulting or Advisory Role - Astellas Pharma
Research Funding - Pfizer
 
Jennifer J. Knox
No Relationships to Disclose
 
Benoit Beuselinck
No Relationships to Disclose
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Janssen; Novartis; Pfizer
Research Funding - Astellas Pharma; Exelixis; Novartis; Pfizer
 
James Brugarolas
No Relationships to Disclose
 
Reuben James Broom
No Relationships to Disclose
 
Aristotelis Bamias
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Novartis; Pfizer
 
Takeshi Yuasa
No Relationships to Disclose
 
Sandhya Srinivas
Consulting or Advisory Role - Genentech/Roche; medivation; pfizer
Research Funding - GlaxoSmithKline
 
D. Scott Ernst
No Relationships to Disclose
 
Carmel Jo Pezaro
Honoraria - Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Lori Wood
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Pfizer (Inst); Roche Canada (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Janssen Oncology; Pfizer
 
Christian K. Kollmannsberger
No Relationships to Disclose
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb (Inst); GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer